medline.ch Gynäkologie Mammae

	Next-generation endocrine therapy in HR+/HER2â€‰-â€‰breast cancer: oral SERDs, ER-targeting innovations, and ctDNA-driven ESR1 mutation-guided switching. Breast Cancer Yao N, Xu G, Duan N, Han F, Li W, Qu J. PMID: 42565973 [PubMed - as supplied by publisher]
	Relationship between bisphosphonate use and risks of recurrence and mortality among hormone receptor-positive and triple-negative breast cancer patients. Cancer Huang L, Cook LS, Tang MC, Doody DR, Peters U, Sun W, Huyghe JR, Malone KE, Li CI. PMID: 42565301 [PubMed - indexed for MEDLINE]
	Ultra-Hypofractionated Palliative Radiotherapy for Symptomatic Locoregionally Advanced Breast Cancer: A Prospective, Single-Arm Phase II Trial of Toxicity and Quality-of-Life Outcomes. Breast Care (Basel) Parambath HK, Gupta S, Thimmarayappa A, Kn YI, Ramdulari AV. PMID: 42565057 [PubMed - as supplied by publisher]
	Triple-Negative Breast Cancer: Predictive Factors for Pathological Complete Response and Prognostic Impact of Clinical, Pathological, and Radiological Parameters. Breast Care (Basel) Zenciroglu M, Abbasoglu P, Y, Topgul OH, Pekuz CK, Bas. PMID: 42565028 [PubMed - as supplied by publisher]
	Portable structured-light 3D volumetry for breast and flap assessment: Technical validation and workflow development. JPRAS Open Chen Y, García-Cañal Á, Xu Y, Wu F, Zapata-Negreiros JA, Cámara-Pérez J, Cuéllar IN, Cuéllar CN, Rebollo-Fernández C, Lasso JM. PMID: 42564832 [PubMed]
	SGLT2 inhibitors and risk of distant metastasis in patients with breast cancer and type 2 diabetes: a target trial emulation with biological plausibility analysis. EClinicalMedicine Chen PH, Chang WC, Jhou HJ, Chen HY, Huang MH, Lee CH. PMID: 42564795 [PubMed]
	Time to diagnosis and treatment and breast cancer outcomes in young women: a systematic review protocol. MethodsX Jacobs W, Atwood T, Gonzalez R, Lee AW. PMID: 42564769 [PubMed]
	Diagnostic performance of Kaiser score, ADC, and their combination for BI-RADS 4 breast lesions: subgroup and misclassification analysis. Front Oncol Zhou H, Wei L, Zhou Z, Jiang G, Li S, Zeng X. PMID: 42564113 [PubMed]
	Essential oil-based interventions for chemotherapy-induced nausea and vomiting in women with breast cancer: a systematic review and meta-analysis. Front Med (Lausanne) Jin K, Yan S, Xu L. PMID: 42564042 [PubMed]
	Tolerance of chemotherapy in breast cancer patients in different age groups: A single-centre South African study. S Afr Med J Zwane AM, Oosthuizen G, Stopforth L, Joffe M, Martin L, . PMID: 42563663 [PubMed - indexed for MEDLINE]
	Clinicopathological features of pregnancy-associated breast cancer at Chris Hani Baragwanath Academic Hospital, South Africa. S Afr Med J Levenberg L, Kruger D, Cubash H, Murugan N. PMID: 42563652 [PubMed - indexed for MEDLINE]
	Hip Mass: Breast Carcinoma. J Coll Physicians Surg Pak Shabbir A, Osmani AH. PMID: 42563353 [PubMed - indexed for MEDLINE]
	Ultrasound-Guided, Indocyanine Green-Directed Robot-Assisted Breast Surgery for Benign Tumours. J Coll Physicians Surg Pak Liu N, Zhang G, Ren C, Cao J, Liao N. PMID: 42563333 [PubMed - indexed for MEDLINE]
	Tissue-stiffness-driven platelet activation emerges as a potential target for breast cancer prevention and treatment. Cell Commun Signal Heenkenda MK, Wang X, Zhong W, Abrahamsson A, Reustle N, Aili D, Lundberg P, Lindahl TL, Dabrosin C. PMID: 42563161 [PubMed - indexed for MEDLINE]
	Understanding barriers and facilitators to breast cancer screening: insights from South Asian women and general practitioners in Victoria, Australia. Aust J Prim Health Rizvi F, White V, Livingston PM, Bellingham K, McLachlan SA, Passey D, Philip J. PMID: 42562622 [PubMed - indexed for MEDLINE]
	(68)Ga-HER2 PET/CT for Predicting Pathologic Response to Neoadjuvant Therapy at Early Treatment and Preoperative Stages in HER2-Positive Breast Cancer: A Prospective Study. J Nucl Med Gao S, Zhang Z, Shi C, Cheng C, Ma X, Zhao X, Liu Y. PMID: 42562610 [PubMed - as supplied by publisher]
	Moderating Role of Perceived Neighborhood Environment on Physical Activity and BMI Outcomes of a Diet and Physical Activity Intervention Among Latina Breast Cancer Survivors. J Phys Act Health Hill CM, Rillamas-Sun E, Marín-Chollom AM, Ulanday KT, Koch PA, Contento IR, Ogden Gaffney A, Hershman DL, Greenlee H. PMID: 42562369 [PubMed - as supplied by publisher]
	Inflammatory breast cancer: improving research and care through the integration of preclinical evidence and technological advances. Crit Rev Oncol Hematol Nicolo E, Manai M, Soliman A, Reduzzi C, Cristofanilli M. PMID: 42562246 [PubMed - as supplied by publisher]
	F11 Receptor/Junctional Adhesion Molecule-A: a novel therapeutic target in breast cancer. Biochimie Bednarek R, . PMID: 42562075 [PubMed - as supplied by publisher]
	Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2-breast cancer: A randomized, phase 2 trial FASCINATE-N. Cell Rep Med Li JJ, Ma LX, Ji P, Chen L, Wu J, Liu GY, Hou YF, Di GH, Hu Z, Jiang YZ, Fan L, Wang ZH, Yu KD, Zhi-Ming Shao. PMID: 42561949 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 220870

Seite 1 von 11044

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung